Toragen Competitors and Similar CompaniesClear all
Toragen's competitors and similar companies include Xencor and Bio-Path Holdings.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. | ||
Founding Date | Founding Date 2016 | Founding Date 1997 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Pasadena, US HQ San Diego, US | Locations Bellaire, US HQ |
Employees | Employees 614% decrease | Employees 2604% increase | Employees 913% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 4 m |
Financial | |||
Net income | Net income N/A | Net income ($92.1m) (FY, 2025) | Net income ($9.9m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 5.4m | Total funding raised $ 108.4m | Total funding raised $ 2.3m |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyBio-Path Holdings
HQ
Bellaire, US
Employees
9↑ 13% increase
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View company